In-Vitro Diagnostics (IVD) Market in UK Size to hit $3.1 billion by 2023, Top Prominent Players: Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG

UPDATE AVAILABLE ON-DEMAND

In-vitro diagnostics (IVD) is the technique in which medical devices and reagents are utilized to analyze biological samples such as blood, urine, stool, tissues, and other body fluids, derived from the human body to detect diseases and infections. In addition, the tests are performed in stand-alone laboratory, and hospital-based laboratory. Some of the significant technologies incorporated in in vitro diagnostics include polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation.

UK IVD market accounted for $2.1 billion in 2016, and is estimated to reach $3.1 billion by 2023, growing at a CAGR of 5.4% during the analysis period (2017-2023).

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/3602

Based on product type, the reagents segment held the highest market share in 2016, owing to the recent introduction of new reagents R&D in the filed for chemical science.

Based on technique, the immunodiagnostics segment contributed the highest market share in 2016, owing to the increase in prevalence of chronic diseases and rise in demand for minimally invasive technique.

Based on application, the infectious diseases segment contributed the highest market share in 2016, due to high rate of the incidences of infectious diseases and rise in awareness of preventive health measures.

Based on end users, the standalone laboratory segment captured the highest market share in 2016, mainly due to wide availability of complex tests and high-tech infrastructure enabling fast and accurate test results.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3602

The Major Key Players Are:

o Thermo Fisher Scientific Inc.
o Alere Inc.
o Biomerieux, Danaher Corporation
o F. Hoffmann-La Roche AG
o Becton Dickinson and Company
o Bio-Rad Laboratories
o Bayer AG
o Sysmex Corporation
o Johnson & Johnson.

Key Findings of the UK IVD Market:

o The immunodiagnostics segment dominated the market in 2016, and is projected to grow at the 5.6% CAGR.
o The immunodiagnostics segment accounted for the highest share in 2016.
o The pathology segment was the major shareholder in the UK IVD based application market in 2016.
o The standalone laboratory segment accounted for the highest share in 2016.
o UK is expected to grow at the highest CAGR in the IVD market.

Access Full Report @ https://www.alliedmarketresearch.com/uk-ivd-market

Similar Reports:

France IVD Market: https://www.alliedmarketresearch.com/france-ivd-market

U.S. IVD Market: https://www.alliedmarketresearch.com/US-IVD-market

IVF Services Market: https://www.alliedmarketresearch.com/IVF-in-vitro-fertilization-services-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.